Argan (ENXTPA:ARG) Stock Faces One Off Gain Distortion Testing Bearish Earnings Narrative

Argan (ENXTPA:ARG) has posted its H1 2026 numbers with trailing 12 month revenue of €258.3 million and basic EPS of €10.37, figures that sit alongside a €105.3 million one off gain that materially skews the headline profitability picture. The company has seen half year revenue move between €109.3 million in H2 2024 and €137.7 million in H1 2025, while basic EPS has ranged from €4.25 to €6.10 over those reported periods. This gives investors a clear view of how the top line and per share earnings have tracked into the latest release. With earnings momentum under pressure and reported margins inflated by that one off item, this set of results puts quality and sustainability of profits front and center for Argan shareholders.

See our full analysis for Argan.

With the headline figures set, the next step is to weigh these results against the widely followed Argan narratives to see which storylines the numbers back up and which ones they call into question.

Curious how numbers become stories that shape markets? Explore Community Narratives

Five year earnings slide at 18.2% a year

• Over the past five years, Argan's earnings declined at an average rate of 18.2% a year, and the analysis notes that earnings over the past year were weaker than that five year average.
• Critics highlight this earnings trend as a bearish signal, and the recent figures give that view some support:
  • H2 2024 net income excluding extra items was €154.8 million, compared with €135.9 million in H1 2025 and €109.3 million in H2 2025, so the most recent half year data in that series sits below the earlier high point.
  • With analysts in the summary expecting earnings to decline about 8.1% a year over the next three years, the backward looking 18.2% annual decline rate reinforces the bearish concern that profitability has been under pressure for a while rather than just in a single period.

€105.3 million one off gain distorts recent profitability

• The last 12 months include a one off gain of €105.3 million, which materially affects trailing net income of €265.5 million on €258.3 million of revenue.
• What stands out for a bearish narrative is how much this single item influences the picture:
  • Trailing 12 month net income excluding extra items is €265.5 million, compared with €245.2 million and €290.7 million in the two prior trailing periods, so the extra €105.3 million gain means reported profitability looks stronger than it would based only on the underlying operations.
  • When combined with the forecast earnings decline of about 8.1% a year, this one off gain backs up the cautious view that recent strength in the numbers may not be a reliable guide to future profit levels.

On top of that distortion, skeptics argue the latest semi annual figures are a stress test of how durable Argan's profit engine really is when one offs are stripped away, and understanding that gap is key before leaning on past margins. 🐻 Argan Bear Case

Low 6.2x P/E and 5.39% yield create a valuation puzzle

• Argan trades on a trailing P/E of 6.2x with a dividend yield of 5.39%, which both sit below the Global Industrial REITs industry P/E of 16.3x and peer average of 19.6x according to the analysis.
• Supporters see this as a bullish opening, but the numbers also invite questions:
  • The analysis notes the stock is trading about 22.1% below the DCF fair value of €82.21, and with the current share price at €64.00 that gap gives bulls a concrete valuation anchor even after factoring in the weaker earnings trend.
  • At the same time, the summary flags that debt is not well covered by operating cash flow, so anyone leaning on the low P/E and relatively high 5.39% income stream needs to set those apparent rewards against the balance sheet coverage risk picked up in the data.

Next Steps

Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Argan's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.

If the push and pull between risks and rewards at Argan feels finely balanced, now is the moment to review the figures yourself and decide where you stand. Then weigh those impressions against the 3 key rewards and 3 important warning signs.

See What Else Is Out There Beyond Argan

Argan's 18.2% yearly earnings slide, one off gain inflated profitability and flagged debt coverage issues together point to pressure on the quality and resilience of its profits.

If that mix of weakening earnings trends and balance sheet concerns makes you cautious, you might compare it with companies that screen well for financial resilience and debt cover through the solid balance sheet and fundamentals stocks screener (420 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com